Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 30;20(4):1220-1227.
doi: 10.5114/aoms/126343. eCollection 2024.

Effect of leptin concentrations and leptin receptor gene polymorphisms on the outcome of renal transplantation

Guadalupe García-Pino  1 , Enrique Luna  2 , Sonia Mota-Zamorano  3 , Luz María González  3 , María Ángeles Tormo  4 , Guillermo Gervasini  3
Affiliations

Effect of leptin concentrations and leptin receptor gene polymorphisms on the outcome of renal transplantation

Guadalupe García-Pino et al. Arch Med Sci. .

Abstract

Introduction: Leptin is a pro-inflammatory adipocytokine implicated in cardiovascular disease, insulin resistance, obesity and chronic kidney disease.

Material and methods: In a cohort of 236 renal transplant recipients, we aimed to determine whether circulating leptin concentrations and/or three polymorphisms in the leptin receptor (LEPR) gene, namely rs1137100, rs1137101 and rs1805094, were related to clinical outcomes in renal transplantation. Plasma leptin concentrations were measured by ELISA. Genetic variants were determined by conventional real-time PCR assays, and statistical associations with clinical outcomes were obtained by logistic regression modelling.

Results: Patients with elevated leptin levels were at higher risk of acute rejection (OR = 1.03 (1.01-1.05), p = 0.03) and displayed worse renal clearance (p = 0.001) than patients with lower levels. Leptin levels were not significantly affected by any of the three LEPR SNPs. The rs1137101 G variant showed an inverse association with the risk of delayed graft function (DGF) (OR = 0.42 (0.22-0.81), p = 0.009), whilst the homozygous rs1805094 CC genotype was associated with increased risk of acute rejection (OR = 11.38 (2.15-60.16), p = 0.004). A statistically significant association was also observed between the rs1137100 GG genotype and better renal function [mean difference vs. AA/AG = 20.20 (4.91-35.49) ml/min, p = 0.010].

Conclusions: Our results show that both leptin plasma concentrations and polymorphisms in the LEPR gene may affect clinical outcomes in renal transplant recipients, suggesting that the determination of these parameters could be useful in predicting post-transplant adverse events.

Keywords: genetic polymorphisms; leptin; leptin receptor; renal transplant.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Distribution of leptin levels according to the occurrence of acute rejection (A) or delayed graft function (DGF) (B). *p < 0.05
Figure 2
Figure 2
Correlation between leptin plasma concentrations and renal function at the time of sampling
Figure 3
Figure 3
Estimated glomerular filtration rate (eGFR) values 1 year after grafting according to the LEPR rs1137100 genotype. *p < 0.05
See this image and copyright information in PMC

References

    1. Malyszko J, Dryl-Rydzynska T, Marcinkowski W, Prystacki T, Malyszko JS. Comorbidities on kidney transplantation waiting list relative to the status of the potential recipient. Arch Med Sci 2018; 14: 941-4. - PMC - PubMed
    1. Nagy K, Nagaraju SP, Rhee CM, Mathe Z, Molnar MZ. Adipocytokines in renal transplant recipients. Clin Kidney J 2016; 9: 359-73. - PMC - PubMed
    1. Gu P, Xu A. Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev Endocr Metab Disord 2013; 14: 49-58. - PubMed
    1. Cumin F, Baum HP, Levens N. Leptin is cleared from the circulation primarily by the kidney. Int J Obes Relat Metab Disord 1996; 20: 1120-6. - PubMed
    1. Zoccali C, Mallamaci F, Tripepi G, et al. . Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134-41. - PubMed